|
M.V. Leonova
A new approach to influencing the renin-angiotensin-aldosterone system: aldosterone synthase inhibitor badrostat
|
№9/10 / 2023
|
|
V.V. Salukhov, B.V. Sagun
Key aspects of cardiovascular damage in COVID-19
|
№9/10 / 2023
|
|
M.V. Leonova
ALISKIREN - NEW DATA OF EVIDENCE-BASED MEDICINE AND PROSPECTS OF APPLICATION.
|
№6 / 2016
|
|
E.I. Astashkin, M.G. Glezer
ROLE OF DIFFERENT TYPES OF RENIN-ANGIOTENSIN SYSTEM IN PATHOGENESIS OF CARDIOVASCULAR DISEASES. FOCUS ON VALSARTAN
|
№13 / 2014
|
|
K.S. Meshkova (1), V.V. Gudkova (2), L.V. Stakhovskaya (2)
DEPENDENCE OF DEVELOPMENT OF STROKE ON ARTERIAL HYPERTENSION AND THE ISSUES OF CHOICE OF ANTIHYPERTENSIVE THERAPY
|
№13 / 2014
|
|
K.A. Gyamdzhyan; M.L. Maksimov
ANGIOTENSIN RECEPTOR BLOCKERS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN THE TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES
|
№13 / 2013
|
|
M.G. Glezer
Therapeutic Measures Aimed At The Prevention Of Postinfarction Heart Remodelling
|
№15 / 2009
|
|
O.A. Kislyak
Possibilities Of Renin-angiotensin-aldosterone System In Patients Of High Cardiovascular Risk
|
№12 / 2009
|
|
E.E. Romanova, A.A. Kirichenko
Influence Of Renin-angiotensin-aldosterone System Blockade On Atrial Fibrillation Course
|
№11 / 2009
|
Русский
